Viewing Study NCT03410693


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-01-01 @ 7:17 PM
Study NCT ID: NCT03410693
Status: COMPLETED
Last Update Posted: 2022-09-28
First Post: 2018-01-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Transitional Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Urothelial carcinoma View